Why the Volpara share price is charging higher today

The Volpara Health Technologies Ltd (ASX:VHT) share price is charging higher after the release of the results of a key medical trial…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Volpara Health Technologies Ltd (ASX: VHT) share price has been a strong performer today.

In afternoon trade the healthcare technology company's shares are up almost 4% to $1.87.

Why is the Volpara share price racing higher?

Investors have been buying Volpara's shares following the release of the results of an eight-year DENSE breast screening trial published in the New England Journal of Medicine.

According to the release, the DENSE trial started collecting patients eight years ago and involved about 40,000 women. It is the first randomised controlled study on the clinical utility of breast MRI supplemental screening for women with extremely dense breasts.

Volpara provided the Dutch researchers with the VolparaDensity software used to automatically and objectively assess breast density in the DENSE trial.

Women whose breasts were judged to be extremely dense were selected for breast MRI screening. The trial assigned 8,061 women to the MRI group, and 32,312 to the mammography-only control group.

The trial found that: "The interval-cancer rate (the number of cancers not detected at screening but found between screenings) was 2.5 per 1,000 in the women invited to have MRI, compared to 5.0 per 1,000 in the control group (P<0.001). 80% of the interval cancers in the MRI group were from women who opted not to have MRI despite being invited. The positive predictive value was 17.4% for recall for additional testing and 26.3% for biopsy. The false positive rate was 79.8 per 1,000 screenings."

Volpara's founder and CEO, Dr Ralph Highnam, believes this will draw attention to ways of making breast screening more effective and is a significant milestone for both Volpara and women globally.

Dr Highnam said: "The evidence from this study is quite clear: using VolparaDensity to assess breast density and then offering MRI screening to women with extremely dense breasts resulted in a significant reduction of 50% in interval cancers. Population-based screening programs now have solid evidence on which to consider the pros and cons of more personalized screening."

Elsewhere in the industry, the ResApp Health Ltd (ASX: RAP) share price is also charging higher today. Investors have been buying its shares after it announced a deal with a telehealth platform provider.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of VOLPARA FPO NZ. The Motley Fool Australia has recommended VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors started the week off in a good mood today.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Bellevue Gold, Bubs, Clarity Pharmaceuticals, and Regal Partners shares are rising today

These shares are starting the week on a positive note.

Read more »

Two people lazing in deck chairs on a beautiful sandy beach throw their hands up in the air.
Travel Shares

Guess which ASX All Ords travel stock just rocketed 17% on an earnings upgrade

Investors are piling into the ASX All Ords travel stock today. Here's what's happening.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »